nodes	percent_of_prediction	percent_of_DWPC	metapath
Nortriptyline—CYP2C9—Medroxyprogesterone Acetate—uterine cancer	0.0759	0.12	CbGbCtD
Nortriptyline—CYP3A5—Progesterone—uterine cancer	0.075	0.119	CbGbCtD
Nortriptyline—CYP2C19—Progesterone—uterine cancer	0.0605	0.0959	CbGbCtD
Nortriptyline—PTGS1—Etoposide—uterine cancer	0.0559	0.0887	CbGbCtD
Nortriptyline—CYP1A2—Progesterone—uterine cancer	0.0558	0.0885	CbGbCtD
Nortriptyline—CYP2C9—Progesterone—uterine cancer	0.0503	0.0798	CbGbCtD
Nortriptyline—CYP2D6—Progesterone—uterine cancer	0.046	0.0729	CbGbCtD
Nortriptyline—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.0441	0.07	CbGbCtD
Nortriptyline—CYP2E1—Etoposide—uterine cancer	0.0432	0.0685	CbGbCtD
Nortriptyline—CYP3A5—Etoposide—uterine cancer	0.0335	0.0532	CbGbCtD
Nortriptyline—CYP3A4—Progesterone—uterine cancer	0.0292	0.0464	CbGbCtD
Nortriptyline—CYP1A2—Etoposide—uterine cancer	0.025	0.0396	CbGbCtD
Nortriptyline—CHRM3—ureter—uterine cancer	0.0147	0.164	CbGeAlD
Nortriptyline—CYP2D6—Doxorubicin—uterine cancer	0.014	0.0223	CbGbCtD
Nortriptyline—CYP3A4—Etoposide—uterine cancer	0.0131	0.0208	CbGbCtD
Nortriptyline—CHRM3—muscle of abdomen—uterine cancer	0.0106	0.118	CbGeAlD
Nortriptyline—CYP3A4—Doxorubicin—uterine cancer	0.00892	0.0142	CbGbCtD
Nortriptyline—PTGS1—oviduct—uterine cancer	0.00329	0.0369	CbGeAlD
Nortriptyline—CHRM3—exocrine gland—uterine cancer	0.00289	0.0324	CbGeAlD
Nortriptyline—CHRM5—epithelium—uterine cancer	0.00225	0.0252	CbGeAlD
Nortriptyline—PTGS1—artery—uterine cancer	0.00218	0.0244	CbGeAlD
Nortriptyline—ADRA1D—epithelium—uterine cancer	0.00201	0.0225	CbGeAlD
Nortriptyline—HTR2A—artery—uterine cancer	0.00197	0.022	CbGeAlD
Nortriptyline—ADRA1B—renal system—uterine cancer	0.0019	0.0213	CbGeAlD
Nortriptyline—ADRA1D—female reproductive system—uterine cancer	0.00149	0.0167	CbGeAlD
Nortriptyline—ORM1—endometrium—uterine cancer	0.00148	0.0166	CbGeAlD
Nortriptyline—ORM1—female reproductive system—uterine cancer	0.00123	0.0138	CbGeAlD
Nortriptyline—CHRM3—smooth muscle tissue—uterine cancer	0.00121	0.0136	CbGeAlD
Nortriptyline—SLC6A2—decidua—uterine cancer	0.00117	0.0131	CbGeAlD
Nortriptyline—CHRM3—renal system—uterine cancer	0.00117	0.0131	CbGeAlD
Nortriptyline—HTR1A—renal system—uterine cancer	0.00116	0.013	CbGeAlD
Nortriptyline—ADRA1A—epithelium—uterine cancer	0.00115	0.0129	CbGeAlD
Nortriptyline—HRH1—myometrium—uterine cancer	0.00114	0.0127	CbGeAlD
Nortriptyline—HTR2C—female reproductive system—uterine cancer	0.0011	0.0124	CbGeAlD
Nortriptyline—ADRA1A—renal system—uterine cancer	0.00107	0.012	CbGeAlD
Nortriptyline—SLC6A4—female reproductive system—uterine cancer	0.00105	0.0117	CbGeAlD
Nortriptyline—CHRM1—female reproductive system—uterine cancer	0.00104	0.0117	CbGeAlD
Nortriptyline—CHRM3—female reproductive system—uterine cancer	0.000933	0.0105	CbGeAlD
Nortriptyline—SLC6A2—female reproductive system—uterine cancer	0.000922	0.0103	CbGeAlD
Nortriptyline—CYP3A5—uterine cervix—uterine cancer	0.000912	0.0102	CbGeAlD
Nortriptyline—HRH1—epithelium—uterine cancer	0.000893	0.01	CbGeAlD
Nortriptyline—HRH1—uterine cervix—uterine cancer	0.000885	0.00992	CbGeAlD
Nortriptyline—CYP1A2—renal system—uterine cancer	0.000885	0.00991	CbGeAlD
Nortriptyline—HRH1—smooth muscle tissue—uterine cancer	0.00086	0.00964	CbGeAlD
Nortriptyline—CYP3A5—renal system—uterine cancer	0.000853	0.00956	CbGeAlD
Nortriptyline—CHRM3—female gonad—uterine cancer	0.000849	0.00951	CbGeAlD
Nortriptyline—HRH1—decidua—uterine cancer	0.000843	0.00945	CbGeAlD
Nortriptyline—PTGS1—epithelium—uterine cancer	0.000826	0.00926	CbGeAlD
Nortriptyline—PTGS1—uterine cervix—uterine cancer	0.000819	0.00918	CbGeAlD
Nortriptyline—HRH1—endometrium—uterine cancer	0.000801	0.00897	CbGeAlD
Nortriptyline—PTGS1—smooth muscle tissue—uterine cancer	0.000796	0.00892	CbGeAlD
Nortriptyline—CYP2E1—renal system—uterine cancer	0.000796	0.00892	CbGeAlD
Nortriptyline—CYP2C19—vagina—uterine cancer	0.000784	0.00879	CbGeAlD
Nortriptyline—HRH1—mammalian vulva—uterine cancer	0.000774	0.00868	CbGeAlD
Nortriptyline—PTGS1—renal system—uterine cancer	0.000767	0.00859	CbGeAlD
Nortriptyline—HTR2A—epithelium—uterine cancer	0.000746	0.00836	CbGeAlD
Nortriptyline—PTGS1—endometrium—uterine cancer	0.000741	0.0083	CbGeAlD
Nortriptyline—ORM1—lymph node—uterine cancer	0.000719	0.00805	CbGeAlD
Nortriptyline—HTR2A—smooth muscle tissue—uterine cancer	0.000718	0.00805	CbGeAlD
Nortriptyline—PTGS1—mammalian vulva—uterine cancer	0.000717	0.00803	CbGeAlD
Nortriptyline—HTR2A—renal system—uterine cancer	0.000692	0.00775	CbGeAlD
Nortriptyline—PTGS1—uterus—uterine cancer	0.000683	0.00765	CbGeAlD
Nortriptyline—CYP2C9—female reproductive system—uterine cancer	0.000672	0.00754	CbGeAlD
Nortriptyline—HRH1—female reproductive system—uterine cancer	0.000663	0.00743	CbGeAlD
Nortriptyline—Feeling abnormal—Progesterone—uterine cancer	0.000641	0.00257	CcSEcCtD
Nortriptyline—CYP3A4—renal system—uterine cancer	0.00064	0.00717	CbGeAlD
Nortriptyline—Insomnia—Medroxyprogesterone Acetate—uterine cancer	0.000637	0.00255	CcSEcCtD
Nortriptyline—CYP2E1—female reproductive system—uterine cancer	0.000637	0.00714	CbGeAlD
Nortriptyline—Coordination abnormal—Epirubicin—uterine cancer	0.000636	0.00255	CcSEcCtD
Nortriptyline—Paraesthesia—Medroxyprogesterone Acetate—uterine cancer	0.000633	0.00254	CcSEcCtD
Nortriptyline—ALB—lymph node—uterine cancer	0.00063	0.00706	CbGeAlD
Nortriptyline—CYP2D6—renal system—uterine cancer	0.00063	0.00706	CbGeAlD
Nortriptyline—Somnolence—Medroxyprogesterone Acetate—uterine cancer	0.000626	0.00251	CcSEcCtD
Nortriptyline—Ventricular tachycardia—Epirubicin—uterine cancer	0.000625	0.0025	CcSEcCtD
Nortriptyline—Ill-defined disorder—Dactinomycin—uterine cancer	0.000625	0.0025	CcSEcCtD
Nortriptyline—Nocturia—Doxorubicin—uterine cancer	0.000623	0.0025	CcSEcCtD
Nortriptyline—CYP3A5—female gonad—uterine cancer	0.000622	0.00697	CbGeAlD
Nortriptyline—Dyspepsia—Medroxyprogesterone Acetate—uterine cancer	0.00062	0.00249	CcSEcCtD
Nortriptyline—CYP3A5—vagina—uterine cancer	0.000618	0.00692	CbGeAlD
Nortriptyline—Urticaria—Progesterone—uterine cancer	0.000618	0.00248	CcSEcCtD
Nortriptyline—Acute coronary syndrome—Etoposide—uterine cancer	0.000615	0.00246	CcSEcCtD
Nortriptyline—Body temperature increased—Progesterone—uterine cancer	0.000615	0.00246	CcSEcCtD
Nortriptyline—Abdominal pain—Progesterone—uterine cancer	0.000615	0.00246	CcSEcCtD
Nortriptyline—PTGS1—female reproductive system—uterine cancer	0.000614	0.00688	CbGeAlD
Nortriptyline—Decreased appetite—Medroxyprogesterone Acetate—uterine cancer	0.000613	0.00245	CcSEcCtD
Nortriptyline—Myocardial infarction—Etoposide—uterine cancer	0.000611	0.00245	CcSEcCtD
Nortriptyline—Neuropathy peripheral—Etoposide—uterine cancer	0.000611	0.00245	CcSEcCtD
Nortriptyline—Jaundice—Etoposide—uterine cancer	0.000608	0.00244	CcSEcCtD
Nortriptyline—Stomatitis—Etoposide—uterine cancer	0.000608	0.00244	CcSEcCtD
Nortriptyline—Fatigue—Medroxyprogesterone Acetate—uterine cancer	0.000607	0.00243	CcSEcCtD
Nortriptyline—Malaise—Dactinomycin—uterine cancer	0.000607	0.00243	CcSEcCtD
Nortriptyline—HRH1—female gonad—uterine cancer	0.000603	0.00676	CbGeAlD
Nortriptyline—Leukopenia—Dactinomycin—uterine cancer	0.000603	0.00242	CcSEcCtD
Nortriptyline—Constipation—Medroxyprogesterone Acetate—uterine cancer	0.000603	0.00241	CcSEcCtD
Nortriptyline—HRH1—vagina—uterine cancer	0.0006	0.00672	CbGeAlD
Nortriptyline—Atrioventricular block—Doxorubicin—uterine cancer	0.000596	0.00239	CcSEcCtD
Nortriptyline—Coordination abnormal—Doxorubicin—uterine cancer	0.000589	0.00236	CcSEcCtD
Nortriptyline—Aplastic anaemia—Epirubicin—uterine cancer	0.000587	0.00235	CcSEcCtD
Nortriptyline—Agranulocytosis—Etoposide—uterine cancer	0.000582	0.00233	CcSEcCtD
Nortriptyline—Feeling abnormal—Medroxyprogesterone Acetate—uterine cancer	0.000581	0.00233	CcSEcCtD
Nortriptyline—Ventricular tachycardia—Doxorubicin—uterine cancer	0.000578	0.00232	CcSEcCtD
Nortriptyline—Hypersensitivity—Progesterone—uterine cancer	0.000573	0.0023	CcSEcCtD
Nortriptyline—Discomfort—Dactinomycin—uterine cancer	0.000566	0.00227	CcSEcCtD
Nortriptyline—Urticaria—Medroxyprogesterone Acetate—uterine cancer	0.00056	0.00224	CcSEcCtD
Nortriptyline—PTGS1—female gonad—uterine cancer	0.000559	0.00626	CbGeAlD
Nortriptyline—Asthenia—Progesterone—uterine cancer	0.000558	0.00224	CcSEcCtD
Nortriptyline—Hypoaesthesia—Etoposide—uterine cancer	0.000557	0.00223	CcSEcCtD
Nortriptyline—Body temperature increased—Medroxyprogesterone Acetate—uterine cancer	0.000557	0.00223	CcSEcCtD
Nortriptyline—Abdominal pain—Medroxyprogesterone Acetate—uterine cancer	0.000557	0.00223	CcSEcCtD
Nortriptyline—PTGS1—vagina—uterine cancer	0.000555	0.00622	CbGeAlD
Nortriptyline—HTR2A—female reproductive system—uterine cancer	0.000554	0.00621	CbGeAlD
Nortriptyline—Pruritus—Progesterone—uterine cancer	0.00055	0.0022	CcSEcCtD
Nortriptyline—Oedema—Dactinomycin—uterine cancer	0.00055	0.0022	CcSEcCtD
Nortriptyline—Aplastic anaemia—Doxorubicin—uterine cancer	0.000543	0.00218	CcSEcCtD
Nortriptyline—SLC6A2—lymph node—uterine cancer	0.000539	0.00604	CbGeAlD
Nortriptyline—Thrombocytopenia—Dactinomycin—uterine cancer	0.000538	0.00216	CcSEcCtD
Nortriptyline—Diarrhoea—Progesterone—uterine cancer	0.000532	0.00213	CcSEcCtD
Nortriptyline—Anorexia—Dactinomycin—uterine cancer	0.000524	0.0021	CcSEcCtD
Nortriptyline—Eye disorder—Etoposide—uterine cancer	0.000523	0.0021	CcSEcCtD
Nortriptyline—Flushing—Etoposide—uterine cancer	0.00052	0.00208	CcSEcCtD
Nortriptyline—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.000519	0.00208	CcSEcCtD
Nortriptyline—Hepatic function abnormal—Epirubicin—uterine cancer	0.000519	0.00208	CcSEcCtD
Nortriptyline—Dizziness—Progesterone—uterine cancer	0.000514	0.00206	CcSEcCtD
Nortriptyline—CYP3A4—female reproductive system—uterine cancer	0.000513	0.00575	CbGeAlD
Nortriptyline—Vascular purpura—Epirubicin—uterine cancer	0.000507	0.00203	CcSEcCtD
Nortriptyline—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.000506	0.00203	CcSEcCtD
Nortriptyline—CYP2D6—female reproductive system—uterine cancer	0.000505	0.00565	CbGeAlD
Nortriptyline—Eye pain—Epirubicin—uterine cancer	0.000503	0.00201	CcSEcCtD
Nortriptyline—HTR2A—vagina—uterine cancer	0.000501	0.00561	CbGeAlD
Nortriptyline—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.000499	0.002	CcSEcCtD
Nortriptyline—Alopecia—Etoposide—uterine cancer	0.000495	0.00198	CcSEcCtD
Nortriptyline—Vomiting—Progesterone—uterine cancer	0.000494	0.00198	CcSEcCtD
Nortriptyline—Rash—Progesterone—uterine cancer	0.00049	0.00196	CcSEcCtD
Nortriptyline—Dermatitis—Progesterone—uterine cancer	0.00049	0.00196	CcSEcCtD
Nortriptyline—Headache—Progesterone—uterine cancer	0.000487	0.00195	CcSEcCtD
Nortriptyline—Hot flush—Epirubicin—uterine cancer	0.000485	0.00194	CcSEcCtD
Nortriptyline—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.000482	0.00193	CcSEcCtD
Nortriptyline—Menopausal symptoms—Epirubicin—uterine cancer	0.000481	0.00193	CcSEcCtD
Nortriptyline—Hepatic function abnormal—Doxorubicin—uterine cancer	0.00048	0.00192	CcSEcCtD
Nortriptyline—Decreased appetite—Dactinomycin—uterine cancer	0.000478	0.00191	CcSEcCtD
Nortriptyline—Dysgeusia—Etoposide—uterine cancer	0.000477	0.00191	CcSEcCtD
Nortriptyline—Fatigue—Dactinomycin—uterine cancer	0.000474	0.0019	CcSEcCtD
Nortriptyline—Purpura—Epirubicin—uterine cancer	0.000471	0.00189	CcSEcCtD
Nortriptyline—Vascular purpura—Doxorubicin—uterine cancer	0.000469	0.00188	CcSEcCtD
Nortriptyline—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.000466	0.00187	CcSEcCtD
Nortriptyline—Eye pain—Doxorubicin—uterine cancer	0.000465	0.00186	CcSEcCtD
Nortriptyline—Cerebrovascular accident—Epirubicin—uterine cancer	0.000463	0.00185	CcSEcCtD
Nortriptyline—Nausea—Progesterone—uterine cancer	0.000462	0.00185	CcSEcCtD
Nortriptyline—CYP2D6—female gonad—uterine cancer	0.000459	0.00514	CbGeAlD
Nortriptyline—Feeling abnormal—Dactinomycin—uterine cancer	0.000453	0.00181	CcSEcCtD
Nortriptyline—Ill-defined disorder—Etoposide—uterine cancer	0.000452	0.00181	CcSEcCtD
Nortriptyline—Hot flush—Doxorubicin—uterine cancer	0.000449	0.0018	CcSEcCtD
Nortriptyline—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.000448	0.0018	CcSEcCtD
Nortriptyline—Menopausal symptoms—Doxorubicin—uterine cancer	0.000445	0.00178	CcSEcCtD
Nortriptyline—Rash—Medroxyprogesterone Acetate—uterine cancer	0.000444	0.00178	CcSEcCtD
Nortriptyline—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.000444	0.00178	CcSEcCtD
Nortriptyline—Headache—Medroxyprogesterone Acetate—uterine cancer	0.000441	0.00177	CcSEcCtD
Nortriptyline—Malaise—Etoposide—uterine cancer	0.00044	0.00176	CcSEcCtD
Nortriptyline—Leukopenia—Etoposide—uterine cancer	0.000436	0.00175	CcSEcCtD
Nortriptyline—Purpura—Doxorubicin—uterine cancer	0.000436	0.00174	CcSEcCtD
Nortriptyline—Abdominal pain—Dactinomycin—uterine cancer	0.000434	0.00174	CcSEcCtD
Nortriptyline—Body temperature increased—Dactinomycin—uterine cancer	0.000434	0.00174	CcSEcCtD
Nortriptyline—Loss of consciousness—Etoposide—uterine cancer	0.000428	0.00172	CcSEcCtD
Nortriptyline—Cerebrovascular accident—Doxorubicin—uterine cancer	0.000428	0.00172	CcSEcCtD
Nortriptyline—Ataxia—Epirubicin—uterine cancer	0.000427	0.00171	CcSEcCtD
Nortriptyline—Convulsion—Etoposide—uterine cancer	0.000422	0.00169	CcSEcCtD
Nortriptyline—Hypertension—Etoposide—uterine cancer	0.000421	0.00169	CcSEcCtD
Nortriptyline—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000419	0.00168	CcSEcCtD
Nortriptyline—Orthostatic hypotension—Epirubicin—uterine cancer	0.000414	0.00166	CcSEcCtD
Nortriptyline—Discomfort—Etoposide—uterine cancer	0.00041	0.00164	CcSEcCtD
Nortriptyline—Hypersensitivity—Dactinomycin—uterine cancer	0.000405	0.00162	CcSEcCtD
Nortriptyline—Confusional state—Etoposide—uterine cancer	0.000401	0.00161	CcSEcCtD
Nortriptyline—Ataxia—Doxorubicin—uterine cancer	0.000395	0.00158	CcSEcCtD
Nortriptyline—Asthenia—Dactinomycin—uterine cancer	0.000394	0.00158	CcSEcCtD
Nortriptyline—Thrombocytopenia—Etoposide—uterine cancer	0.000389	0.00156	CcSEcCtD
Nortriptyline—Tachycardia—Etoposide—uterine cancer	0.000388	0.00156	CcSEcCtD
Nortriptyline—Eosinophilia—Epirubicin—uterine cancer	0.000388	0.00156	CcSEcCtD
Nortriptyline—HRH1—lymph node—uterine cancer	0.000388	0.00435	CbGeAlD
Nortriptyline—Hyperhidrosis—Etoposide—uterine cancer	0.000385	0.00154	CcSEcCtD
Nortriptyline—Orthostatic hypotension—Doxorubicin—uterine cancer	0.000383	0.00154	CcSEcCtD
Nortriptyline—Anorexia—Etoposide—uterine cancer	0.000379	0.00152	CcSEcCtD
Nortriptyline—Diarrhoea—Dactinomycin—uterine cancer	0.000376	0.00151	CcSEcCtD
Nortriptyline—Pancytopenia—Epirubicin—uterine cancer	0.000372	0.00149	CcSEcCtD
Nortriptyline—Hypotension—Etoposide—uterine cancer	0.000372	0.00149	CcSEcCtD
Nortriptyline—Pollakiuria—Epirubicin—uterine cancer	0.000362	0.00145	CcSEcCtD
Nortriptyline—Eosinophilia—Doxorubicin—uterine cancer	0.000359	0.00144	CcSEcCtD
Nortriptyline—PTGS1—lymph node—uterine cancer	0.000359	0.00402	CbGeAlD
Nortriptyline—Paraesthesia—Etoposide—uterine cancer	0.000357	0.00143	CcSEcCtD
Nortriptyline—Weight increased—Epirubicin—uterine cancer	0.000357	0.00143	CcSEcCtD
Nortriptyline—Weight decreased—Epirubicin—uterine cancer	0.000355	0.00142	CcSEcCtD
Nortriptyline—Somnolence—Etoposide—uterine cancer	0.000354	0.00142	CcSEcCtD
Nortriptyline—Drowsiness—Epirubicin—uterine cancer	0.00035	0.0014	CcSEcCtD
Nortriptyline—Vomiting—Dactinomycin—uterine cancer	0.000349	0.0014	CcSEcCtD
Nortriptyline—Rash—Dactinomycin—uterine cancer	0.000347	0.00139	CcSEcCtD
Nortriptyline—Decreased appetite—Etoposide—uterine cancer	0.000346	0.00139	CcSEcCtD
Nortriptyline—Pancytopenia—Doxorubicin—uterine cancer	0.000345	0.00138	CcSEcCtD
Nortriptyline—Fatigue—Etoposide—uterine cancer	0.000343	0.00137	CcSEcCtD
Nortriptyline—Neuropathy peripheral—Epirubicin—uterine cancer	0.000343	0.00137	CcSEcCtD
Nortriptyline—Stomatitis—Epirubicin—uterine cancer	0.000341	0.00137	CcSEcCtD
Nortriptyline—Jaundice—Epirubicin—uterine cancer	0.000341	0.00137	CcSEcCtD
Nortriptyline—Constipation—Etoposide—uterine cancer	0.00034	0.00136	CcSEcCtD
Nortriptyline—Sweating—Epirubicin—uterine cancer	0.000335	0.00134	CcSEcCtD
Nortriptyline—Pollakiuria—Doxorubicin—uterine cancer	0.000335	0.00134	CcSEcCtD
Nortriptyline—Weight increased—Doxorubicin—uterine cancer	0.00033	0.00132	CcSEcCtD
Nortriptyline—Weight decreased—Doxorubicin—uterine cancer	0.000328	0.00132	CcSEcCtD
Nortriptyline—Feeling abnormal—Etoposide—uterine cancer	0.000328	0.00131	CcSEcCtD
Nortriptyline—Nausea—Dactinomycin—uterine cancer	0.000326	0.00131	CcSEcCtD
Nortriptyline—Agranulocytosis—Epirubicin—uterine cancer	0.000326	0.00131	CcSEcCtD
Nortriptyline—Drowsiness—Doxorubicin—uterine cancer	0.000323	0.0013	CcSEcCtD
Nortriptyline—Neuropathy peripheral—Doxorubicin—uterine cancer	0.000317	0.00127	CcSEcCtD
Nortriptyline—Urticaria—Etoposide—uterine cancer	0.000316	0.00127	CcSEcCtD
Nortriptyline—Stomatitis—Doxorubicin—uterine cancer	0.000315	0.00126	CcSEcCtD
Nortriptyline—Jaundice—Doxorubicin—uterine cancer	0.000315	0.00126	CcSEcCtD
Nortriptyline—Abdominal pain—Etoposide—uterine cancer	0.000314	0.00126	CcSEcCtD
Nortriptyline—Body temperature increased—Etoposide—uterine cancer	0.000314	0.00126	CcSEcCtD
Nortriptyline—Hepatitis—Epirubicin—uterine cancer	0.000314	0.00126	CcSEcCtD
Nortriptyline—Hypoaesthesia—Epirubicin—uterine cancer	0.000312	0.00125	CcSEcCtD
Nortriptyline—Sweating—Doxorubicin—uterine cancer	0.00031	0.00124	CcSEcCtD
Nortriptyline—Oedema peripheral—Epirubicin—uterine cancer	0.000309	0.00124	CcSEcCtD
Nortriptyline—Agranulocytosis—Doxorubicin—uterine cancer	0.000302	0.00121	CcSEcCtD
Nortriptyline—Eye disorder—Epirubicin—uterine cancer	0.000293	0.00118	CcSEcCtD
Nortriptyline—Hypersensitivity—Etoposide—uterine cancer	0.000293	0.00117	CcSEcCtD
Nortriptyline—Tinnitus—Epirubicin—uterine cancer	0.000293	0.00117	CcSEcCtD
Nortriptyline—Flushing—Epirubicin—uterine cancer	0.000291	0.00117	CcSEcCtD
Nortriptyline—Hepatitis—Doxorubicin—uterine cancer	0.00029	0.00116	CcSEcCtD
Nortriptyline—Hypoaesthesia—Doxorubicin—uterine cancer	0.000289	0.00116	CcSEcCtD
Nortriptyline—Oedema peripheral—Doxorubicin—uterine cancer	0.000286	0.00115	CcSEcCtD
Nortriptyline—Asthenia—Etoposide—uterine cancer	0.000285	0.00114	CcSEcCtD
Nortriptyline—Pruritus—Etoposide—uterine cancer	0.000281	0.00113	CcSEcCtD
Nortriptyline—Arrhythmia—Epirubicin—uterine cancer	0.00028	0.00112	CcSEcCtD
Nortriptyline—Alopecia—Epirubicin—uterine cancer	0.000277	0.00111	CcSEcCtD
Nortriptyline—Diarrhoea—Etoposide—uterine cancer	0.000272	0.00109	CcSEcCtD
Nortriptyline—Eye disorder—Doxorubicin—uterine cancer	0.000271	0.00109	CcSEcCtD
Nortriptyline—Tinnitus—Doxorubicin—uterine cancer	0.000271	0.00108	CcSEcCtD
Nortriptyline—Flushing—Doxorubicin—uterine cancer	0.00027	0.00108	CcSEcCtD
Nortriptyline—Tension—Epirubicin—uterine cancer	0.000268	0.00107	CcSEcCtD
Nortriptyline—Dysgeusia—Epirubicin—uterine cancer	0.000268	0.00107	CcSEcCtD
Nortriptyline—Nervousness—Epirubicin—uterine cancer	0.000265	0.00106	CcSEcCtD
Nortriptyline—Dizziness—Etoposide—uterine cancer	0.000263	0.00105	CcSEcCtD
Nortriptyline—Arrhythmia—Doxorubicin—uterine cancer	0.000259	0.00104	CcSEcCtD
Nortriptyline—Vision blurred—Epirubicin—uterine cancer	0.000257	0.00103	CcSEcCtD
Nortriptyline—Alopecia—Doxorubicin—uterine cancer	0.000257	0.00103	CcSEcCtD
Nortriptyline—Ill-defined disorder—Epirubicin—uterine cancer	0.000253	0.00102	CcSEcCtD
Nortriptyline—Vomiting—Etoposide—uterine cancer	0.000253	0.00101	CcSEcCtD
Nortriptyline—Agitation—Epirubicin—uterine cancer	0.000251	0.00101	CcSEcCtD
Nortriptyline—Rash—Etoposide—uterine cancer	0.000251	0.001	CcSEcCtD
Nortriptyline—Dermatitis—Etoposide—uterine cancer	0.000251	0.001	CcSEcCtD
Nortriptyline—Headache—Etoposide—uterine cancer	0.000249	0.000998	CcSEcCtD
Nortriptyline—Tension—Doxorubicin—uterine cancer	0.000248	0.000994	CcSEcCtD
Nortriptyline—Dysgeusia—Doxorubicin—uterine cancer	0.000248	0.000992	CcSEcCtD
Nortriptyline—Malaise—Epirubicin—uterine cancer	0.000246	0.000987	CcSEcCtD
Nortriptyline—Nervousness—Doxorubicin—uterine cancer	0.000246	0.000984	CcSEcCtD
Nortriptyline—Syncope—Epirubicin—uterine cancer	0.000245	0.000982	CcSEcCtD
Nortriptyline—Leukopenia—Epirubicin—uterine cancer	0.000245	0.00098	CcSEcCtD
Nortriptyline—Palpitations—Epirubicin—uterine cancer	0.000241	0.000967	CcSEcCtD
Nortriptyline—Loss of consciousness—Epirubicin—uterine cancer	0.00024	0.000962	CcSEcCtD
Nortriptyline—Vision blurred—Doxorubicin—uterine cancer	0.000238	0.000955	CcSEcCtD
Nortriptyline—Convulsion—Epirubicin—uterine cancer	0.000237	0.000948	CcSEcCtD
Nortriptyline—Nausea—Etoposide—uterine cancer	0.000236	0.000947	CcSEcCtD
Nortriptyline—Hypertension—Epirubicin—uterine cancer	0.000236	0.000945	CcSEcCtD
Nortriptyline—Ill-defined disorder—Doxorubicin—uterine cancer	0.000235	0.00094	CcSEcCtD
Nortriptyline—Agitation—Doxorubicin—uterine cancer	0.000232	0.000931	CcSEcCtD
Nortriptyline—Anxiety—Epirubicin—uterine cancer	0.000232	0.000929	CcSEcCtD
Nortriptyline—Discomfort—Epirubicin—uterine cancer	0.00023	0.000921	CcSEcCtD
Nortriptyline—Malaise—Doxorubicin—uterine cancer	0.000228	0.000913	CcSEcCtD
Nortriptyline—Dry mouth—Epirubicin—uterine cancer	0.000227	0.000911	CcSEcCtD
Nortriptyline—Syncope—Doxorubicin—uterine cancer	0.000227	0.000908	CcSEcCtD
Nortriptyline—Leukopenia—Doxorubicin—uterine cancer	0.000226	0.000907	CcSEcCtD
Nortriptyline—Confusional state—Epirubicin—uterine cancer	0.000225	0.000901	CcSEcCtD
Nortriptyline—Palpitations—Doxorubicin—uterine cancer	0.000223	0.000895	CcSEcCtD
Nortriptyline—Oedema—Epirubicin—uterine cancer	0.000223	0.000893	CcSEcCtD
Nortriptyline—Loss of consciousness—Doxorubicin—uterine cancer	0.000222	0.00089	CcSEcCtD
Nortriptyline—Shock—Epirubicin—uterine cancer	0.000219	0.000879	CcSEcCtD
Nortriptyline—Convulsion—Doxorubicin—uterine cancer	0.000219	0.000878	CcSEcCtD
Nortriptyline—Thrombocytopenia—Epirubicin—uterine cancer	0.000218	0.000875	CcSEcCtD
Nortriptyline—Hypertension—Doxorubicin—uterine cancer	0.000218	0.000874	CcSEcCtD
Nortriptyline—Tachycardia—Epirubicin—uterine cancer	0.000218	0.000872	CcSEcCtD
Nortriptyline—Hyperhidrosis—Epirubicin—uterine cancer	0.000216	0.000864	CcSEcCtD
Nortriptyline—Anxiety—Doxorubicin—uterine cancer	0.000214	0.000859	CcSEcCtD
Nortriptyline—Discomfort—Doxorubicin—uterine cancer	0.000213	0.000852	CcSEcCtD
Nortriptyline—Anorexia—Epirubicin—uterine cancer	0.000213	0.000852	CcSEcCtD
Nortriptyline—Dry mouth—Doxorubicin—uterine cancer	0.00021	0.000843	CcSEcCtD
Nortriptyline—Hypotension—Epirubicin—uterine cancer	0.000208	0.000835	CcSEcCtD
Nortriptyline—Confusional state—Doxorubicin—uterine cancer	0.000208	0.000833	CcSEcCtD
Nortriptyline—Oedema—Doxorubicin—uterine cancer	0.000206	0.000827	CcSEcCtD
Nortriptyline—Shock—Doxorubicin—uterine cancer	0.000203	0.000813	CcSEcCtD
Nortriptyline—Thrombocytopenia—Doxorubicin—uterine cancer	0.000202	0.000809	CcSEcCtD
Nortriptyline—Insomnia—Epirubicin—uterine cancer	0.000202	0.000808	CcSEcCtD
Nortriptyline—Tachycardia—Doxorubicin—uterine cancer	0.000201	0.000807	CcSEcCtD
Nortriptyline—Paraesthesia—Epirubicin—uterine cancer	0.0002	0.000802	CcSEcCtD
Nortriptyline—Hyperhidrosis—Doxorubicin—uterine cancer	0.000199	0.000799	CcSEcCtD
Nortriptyline—Somnolence—Epirubicin—uterine cancer	0.000198	0.000794	CcSEcCtD
Nortriptyline—Anorexia—Doxorubicin—uterine cancer	0.000197	0.000788	CcSEcCtD
Nortriptyline—Dyspepsia—Epirubicin—uterine cancer	0.000196	0.000786	CcSEcCtD
Nortriptyline—Decreased appetite—Epirubicin—uterine cancer	0.000194	0.000777	CcSEcCtD
Nortriptyline—Hypotension—Doxorubicin—uterine cancer	0.000193	0.000772	CcSEcCtD
Nortriptyline—Fatigue—Epirubicin—uterine cancer	0.000192	0.00077	CcSEcCtD
Nortriptyline—Constipation—Epirubicin—uterine cancer	0.000191	0.000764	CcSEcCtD
Nortriptyline—Insomnia—Doxorubicin—uterine cancer	0.000187	0.000748	CcSEcCtD
Nortriptyline—Paraesthesia—Doxorubicin—uterine cancer	0.000185	0.000742	CcSEcCtD
Nortriptyline—Feeling abnormal—Epirubicin—uterine cancer	0.000184	0.000736	CcSEcCtD
Nortriptyline—Somnolence—Doxorubicin—uterine cancer	0.000183	0.000735	CcSEcCtD
Nortriptyline—Dyspepsia—Doxorubicin—uterine cancer	0.000182	0.000728	CcSEcCtD
Nortriptyline—Decreased appetite—Doxorubicin—uterine cancer	0.000179	0.000719	CcSEcCtD
Nortriptyline—Fatigue—Doxorubicin—uterine cancer	0.000178	0.000713	CcSEcCtD
Nortriptyline—Urticaria—Epirubicin—uterine cancer	0.000177	0.00071	CcSEcCtD
Nortriptyline—Constipation—Doxorubicin—uterine cancer	0.000176	0.000707	CcSEcCtD
Nortriptyline—Abdominal pain—Epirubicin—uterine cancer	0.000176	0.000706	CcSEcCtD
Nortriptyline—Body temperature increased—Epirubicin—uterine cancer	0.000176	0.000706	CcSEcCtD
Nortriptyline—Feeling abnormal—Doxorubicin—uterine cancer	0.00017	0.000681	CcSEcCtD
Nortriptyline—Hypersensitivity—Epirubicin—uterine cancer	0.000164	0.000658	CcSEcCtD
Nortriptyline—Urticaria—Doxorubicin—uterine cancer	0.000164	0.000657	CcSEcCtD
Nortriptyline—Abdominal pain—Doxorubicin—uterine cancer	0.000163	0.000653	CcSEcCtD
Nortriptyline—Body temperature increased—Doxorubicin—uterine cancer	0.000163	0.000653	CcSEcCtD
Nortriptyline—Asthenia—Epirubicin—uterine cancer	0.00016	0.000641	CcSEcCtD
Nortriptyline—Pruritus—Epirubicin—uterine cancer	0.000158	0.000632	CcSEcCtD
Nortriptyline—Diarrhoea—Epirubicin—uterine cancer	0.000153	0.000611	CcSEcCtD
Nortriptyline—Hypersensitivity—Doxorubicin—uterine cancer	0.000152	0.000609	CcSEcCtD
Nortriptyline—Asthenia—Doxorubicin—uterine cancer	0.000148	0.000593	CcSEcCtD
Nortriptyline—Dizziness—Epirubicin—uterine cancer	0.000147	0.000591	CcSEcCtD
Nortriptyline—Pruritus—Doxorubicin—uterine cancer	0.000146	0.000585	CcSEcCtD
Nortriptyline—Vomiting—Epirubicin—uterine cancer	0.000142	0.000568	CcSEcCtD
Nortriptyline—Diarrhoea—Doxorubicin—uterine cancer	0.000141	0.000566	CcSEcCtD
Nortriptyline—Rash—Epirubicin—uterine cancer	0.000141	0.000563	CcSEcCtD
Nortriptyline—Dermatitis—Epirubicin—uterine cancer	0.00014	0.000563	CcSEcCtD
Nortriptyline—Headache—Epirubicin—uterine cancer	0.00014	0.00056	CcSEcCtD
Nortriptyline—Dizziness—Doxorubicin—uterine cancer	0.000136	0.000547	CcSEcCtD
Nortriptyline—Nausea—Epirubicin—uterine cancer	0.000132	0.000531	CcSEcCtD
Nortriptyline—Vomiting—Doxorubicin—uterine cancer	0.000131	0.000526	CcSEcCtD
Nortriptyline—Rash—Doxorubicin—uterine cancer	0.00013	0.000521	CcSEcCtD
Nortriptyline—Dermatitis—Doxorubicin—uterine cancer	0.00013	0.000521	CcSEcCtD
Nortriptyline—Headache—Doxorubicin—uterine cancer	0.000129	0.000518	CcSEcCtD
Nortriptyline—Nausea—Doxorubicin—uterine cancer	0.000123	0.000491	CcSEcCtD
Nortriptyline—CHRM3—GPCR downstream signaling—PIK3CA—uterine cancer	4.9e-06	0.000159	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling by GPCR—KRAS—uterine cancer	4.89e-06	0.000159	CbGpPWpGaD
Nortriptyline—HRH1—Signaling by GPCR—KRAS—uterine cancer	4.88e-06	0.000158	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling by GPCR—AKT1—uterine cancer	4.87e-06	0.000158	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling by GPCR—KRAS—uterine cancer	4.86e-06	0.000158	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—ERBB2—uterine cancer	4.86e-06	0.000158	CbGpPWpGaD
Nortriptyline—CHRM2—GPCR downstream signaling—PIK3CA—uterine cancer	4.85e-06	0.000158	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling by GPCR—KRAS—uterine cancer	4.85e-06	0.000157	CbGpPWpGaD
Nortriptyline—ADRA1A—GPCR downstream signaling—PIK3CA—uterine cancer	4.84e-06	0.000157	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—CXCL8—uterine cancer	4.84e-06	0.000157	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism of lipids and lipoproteins—EP300—uterine cancer	4.84e-06	0.000157	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—CXCL8—uterine cancer	4.81e-06	0.000156	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling by GPCR—HRAS—uterine cancer	4.81e-06	0.000156	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling by GPCR—KRAS—uterine cancer	4.8e-06	0.000156	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—VEGFA—uterine cancer	4.8e-06	0.000156	CbGpPWpGaD
Nortriptyline—PTGS1—Metabolism—EP300—uterine cancer	4.79e-06	0.000156	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—MTHFR—uterine cancer	4.79e-06	0.000156	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling by GPCR—KRAS—uterine cancer	4.79e-06	0.000155	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling by GPCR—HRAS—uterine cancer	4.78e-06	0.000155	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—EP300—uterine cancer	4.76e-06	0.000155	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—MTHFR—uterine cancer	4.75e-06	0.000154	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—NRAS—uterine cancer	4.74e-06	0.000154	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—CDKN1B—uterine cancer	4.73e-06	0.000153	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—CDKN1B—uterine cancer	4.7e-06	0.000153	CbGpPWpGaD
Nortriptyline—HTR1A—GPCR downstream signaling—AKT1—uterine cancer	4.68e-06	0.000152	CbGpPWpGaD
Nortriptyline—HTR2C—GPCR downstream signaling—AKT1—uterine cancer	4.65e-06	0.000151	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—CXCL8—uterine cancer	4.61e-06	0.00015	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	4.59e-06	0.000149	CbGpPWpGaD
Nortriptyline—ALB—Hemostasis—AKT1—uterine cancer	4.59e-06	0.000149	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling by GPCR—HRAS—uterine cancer	4.58e-06	0.000149	CbGpPWpGaD
Nortriptyline—DRD2—Signaling by GPCR—PIK3CA—uterine cancer	4.56e-06	0.000148	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—KRAS—uterine cancer	4.51e-06	0.000147	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—VEGFA—uterine cancer	4.51e-06	0.000146	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—CDKN1B—uterine cancer	4.5e-06	0.000146	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling by GPCR—PIK3CA—uterine cancer	4.49e-06	0.000146	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—ERBB2—uterine cancer	4.48e-06	0.000145	CbGpPWpGaD
Nortriptyline—HRH1—Signaling by GPCR—PIK3CA—uterine cancer	4.48e-06	0.000145	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling by GPCR—PIK3CA—uterine cancer	4.47e-06	0.000145	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—CTNNB1—uterine cancer	4.47e-06	0.000145	CbGpPWpGaD
Nortriptyline—CHRM3—Metabolism—PTEN—uterine cancer	4.46e-06	0.000145	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—NRAS—uterine cancer	4.45e-06	0.000145	CbGpPWpGaD
Nortriptyline—ADRA1B—GPCR downstream signaling—AKT1—uterine cancer	4.45e-06	0.000145	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling by GPCR—PIK3CA—uterine cancer	4.45e-06	0.000145	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—CTNNB1—uterine cancer	4.44e-06	0.000144	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—ERBB2—uterine cancer	4.41e-06	0.000143	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling by GPCR—PIK3CA—uterine cancer	4.41e-06	0.000143	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—ERBB2—uterine cancer	4.4e-06	0.000143	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling by GPCR—PIK3CA—uterine cancer	4.4e-06	0.000143	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—ERBB2—uterine cancer	4.39e-06	0.000142	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—ERBB2—uterine cancer	4.37e-06	0.000142	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—PTEN—uterine cancer	4.35e-06	0.000141	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—PTEN—uterine cancer	4.33e-06	0.000141	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—ERBB2—uterine cancer	4.33e-06	0.000141	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—ERBB2—uterine cancer	4.32e-06	0.00014	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—KRAS—uterine cancer	4.26e-06	0.000138	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—CTNNB1—uterine cancer	4.25e-06	0.000138	CbGpPWpGaD
Nortriptyline—CHRM3—Metabolism—EP300—uterine cancer	4.25e-06	0.000138	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—CXCL8—uterine cancer	4.25e-06	0.000138	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling by GPCR—AKT1—uterine cancer	4.25e-06	0.000138	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling by GPCR—AKT1—uterine cancer	4.22e-06	0.000137	CbGpPWpGaD
Nortriptyline—DRD2—Signaling by GPCR—HRAS—uterine cancer	4.22e-06	0.000137	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	4.19e-06	0.000136	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—CXCL8—uterine cancer	4.18e-06	0.000136	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—CXCL8—uterine cancer	4.17e-06	0.000135	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—STK11—uterine cancer	4.17e-06	0.000135	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—CYP19A1—uterine cancer	4.17e-06	0.000135	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—CXCL8—uterine cancer	4.16e-06	0.000135	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling by GPCR—HRAS—uterine cancer	4.15e-06	0.000135	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—EP300—uterine cancer	4.15e-06	0.000135	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—CDKN1B—uterine cancer	4.15e-06	0.000135	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—PIK3CA—uterine cancer	4.15e-06	0.000135	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—CXCL8—uterine cancer	4.15e-06	0.000135	CbGpPWpGaD
Nortriptyline—HRH1—Signaling by GPCR—HRAS—uterine cancer	4.15e-06	0.000135	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—PTEN—uterine cancer	4.14e-06	0.000135	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling by GPCR—HRAS—uterine cancer	4.13e-06	0.000134	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—EP300—uterine cancer	4.13e-06	0.000134	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling by GPCR—HRAS—uterine cancer	4.12e-06	0.000134	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—CXCL8—uterine cancer	4.11e-06	0.000133	CbGpPWpGaD
Nortriptyline—DRD2—GPCR downstream signaling—AKT1—uterine cancer	4.1e-06	0.000133	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—CXCL8—uterine cancer	4.09e-06	0.000133	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—CDKN1B—uterine cancer	4.08e-06	0.000133	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling by GPCR—HRAS—uterine cancer	4.08e-06	0.000132	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—KRAS—uterine cancer	4.08e-06	0.000132	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—CDKN1B—uterine cancer	4.07e-06	0.000132	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling by GPCR—HRAS—uterine cancer	4.07e-06	0.000132	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—CDKN1B—uterine cancer	4.06e-06	0.000132	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—MTHFR—uterine cancer	4.06e-06	0.000132	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—CDKN1B—uterine cancer	4.05e-06	0.000131	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling by GPCR—AKT1—uterine cancer	4.04e-06	0.000131	CbGpPWpGaD
Nortriptyline—HTR2A—GPCR downstream signaling—AKT1—uterine cancer	4.04e-06	0.000131	CbGpPWpGaD
Nortriptyline—HRH1—GPCR downstream signaling—AKT1—uterine cancer	4.03e-06	0.000131	CbGpPWpGaD
Nortriptyline—CHRM1—GPCR downstream signaling—AKT1—uterine cancer	4.02e-06	0.00013	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—TP53—uterine cancer	4.01e-06	0.00013	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—CDKN1B—uterine cancer	4.01e-06	0.00013	CbGpPWpGaD
Nortriptyline—CHRM3—GPCR downstream signaling—AKT1—uterine cancer	4e-06	0.00013	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—CDKN1B—uterine cancer	4e-06	0.00013	CbGpPWpGaD
Nortriptyline—CHRM2—GPCR downstream signaling—AKT1—uterine cancer	3.97e-06	0.000129	CbGpPWpGaD
Nortriptyline—ADRA1A—GPCR downstream signaling—AKT1—uterine cancer	3.95e-06	0.000128	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—EP300—uterine cancer	3.95e-06	0.000128	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—VEGFA—uterine cancer	3.93e-06	0.000128	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—CTNNB1—uterine cancer	3.92e-06	0.000127	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—PIK3CA—uterine cancer	3.91e-06	0.000127	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—VEGFA—uterine cancer	3.91e-06	0.000127	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—NRAS—uterine cancer	3.88e-06	0.000126	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—NRAS—uterine cancer	3.86e-06	0.000125	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—CTNNB1—uterine cancer	3.86e-06	0.000125	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—CTNNB1—uterine cancer	3.85e-06	0.000125	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—HRAS—uterine cancer	3.84e-06	0.000125	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—CTNNB1—uterine cancer	3.84e-06	0.000125	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—KRAS—uterine cancer	3.83e-06	0.000124	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—CTNNB1—uterine cancer	3.82e-06	0.000124	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—PTEN—uterine cancer	3.82e-06	0.000124	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—CTNNB1—uterine cancer	3.79e-06	0.000123	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—TP53—uterine cancer	3.78e-06	0.000123	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—CTNNB1—uterine cancer	3.78e-06	0.000123	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—PTEN—uterine cancer	3.76e-06	0.000122	CbGpPWpGaD
Nortriptyline—CYP2E1—Metabolism—PTEN—uterine cancer	3.76e-06	0.000122	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—PTEN—uterine cancer	3.75e-06	0.000122	CbGpPWpGaD
Nortriptyline—CYP3A5—Metabolism—PTEN—uterine cancer	3.75e-06	0.000122	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—PIK3CA—uterine cancer	3.75e-06	0.000122	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—VEGFA—uterine cancer	3.74e-06	0.000122	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—PTEN—uterine cancer	3.74e-06	0.000121	CbGpPWpGaD
Nortriptyline—DRD2—Signaling by GPCR—AKT1—uterine cancer	3.73e-06	0.000121	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—PTEN—uterine cancer	3.73e-06	0.000121	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—NRAS—uterine cancer	3.7e-06	0.00012	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—PTEN—uterine cancer	3.69e-06	0.00012	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—PTEN—uterine cancer	3.68e-06	0.00012	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling by GPCR—AKT1—uterine cancer	3.67e-06	0.000119	CbGpPWpGaD
Nortriptyline—HRH1—Signaling by GPCR—AKT1—uterine cancer	3.66e-06	0.000119	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling by GPCR—AKT1—uterine cancer	3.65e-06	0.000118	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—EP300—uterine cancer	3.64e-06	0.000118	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling by GPCR—AKT1—uterine cancer	3.64e-06	0.000118	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—TP53—uterine cancer	3.62e-06	0.000118	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—HRAS—uterine cancer	3.62e-06	0.000118	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling by GPCR—AKT1—uterine cancer	3.6e-06	0.000117	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling by GPCR—AKT1—uterine cancer	3.59e-06	0.000117	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—EP300—uterine cancer	3.59e-06	0.000116	CbGpPWpGaD
Nortriptyline—CYP2E1—Metabolism—EP300—uterine cancer	3.58e-06	0.000116	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—EP300—uterine cancer	3.58e-06	0.000116	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	3.58e-06	0.000116	CbGpPWpGaD
Nortriptyline—CYP3A5—Metabolism—EP300—uterine cancer	3.57e-06	0.000116	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—EP300—uterine cancer	3.57e-06	0.000116	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—EP300—uterine cancer	3.55e-06	0.000115	CbGpPWpGaD
Nortriptyline—PTGS1—Metabolism—PIK3CA—uterine cancer	3.55e-06	0.000115	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—PIK3CA—uterine cancer	3.52e-06	0.000114	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—EP300—uterine cancer	3.52e-06	0.000114	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—EP300—uterine cancer	3.51e-06	0.000114	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—HRAS—uterine cancer	3.47e-06	0.000113	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—VEGFA—uterine cancer	3.45e-06	0.000112	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—NRAS—uterine cancer	3.41e-06	0.000111	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—TP53—uterine cancer	3.41e-06	0.000111	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—VEGFA—uterine cancer	3.4e-06	0.00011	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—VEGFA—uterine cancer	3.39e-06	0.00011	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—AKT1—uterine cancer	3.39e-06	0.00011	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—VEGFA—uterine cancer	3.38e-06	0.00011	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—VEGFA—uterine cancer	3.37e-06	0.000109	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—NRAS—uterine cancer	3.35e-06	0.000109	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—NRAS—uterine cancer	3.35e-06	0.000109	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—KRAS—uterine cancer	3.34e-06	0.000108	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—NRAS—uterine cancer	3.34e-06	0.000108	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—VEGFA—uterine cancer	3.33e-06	0.000108	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—NRAS—uterine cancer	3.33e-06	0.000108	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—VEGFA—uterine cancer	3.33e-06	0.000108	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—KRAS—uterine cancer	3.32e-06	0.000108	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—NRAS—uterine cancer	3.29e-06	0.000107	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—NRAS—uterine cancer	3.28e-06	0.000107	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—HRAS—uterine cancer	3.26e-06	0.000106	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—PTEN—uterine cancer	3.23e-06	0.000105	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—AKT1—uterine cancer	3.2e-06	0.000104	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—KRAS—uterine cancer	3.18e-06	0.000103	CbGpPWpGaD
Nortriptyline—CHRM3—Metabolism—PIK3CA—uterine cancer	3.14e-06	0.000102	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—MTHFR—uterine cancer	3.13e-06	0.000102	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—EP300—uterine cancer	3.08e-06	9.99e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—PIK3CA—uterine cancer	3.07e-06	9.97e-05	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—AKT1—uterine cancer	3.06e-06	9.94e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—PIK3CA—uterine cancer	3.05e-06	9.91e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—TP53—uterine cancer	2.97e-06	9.64e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—TP53—uterine cancer	2.95e-06	9.59e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—KRAS—uterine cancer	2.93e-06	9.52e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—PIK3CA—uterine cancer	2.92e-06	9.49e-05	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—PTEN—uterine cancer	2.9e-06	9.41e-05	CbGpPWpGaD
Nortriptyline—PTGS1—Metabolism—AKT1—uterine cancer	2.9e-06	9.4e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—KRAS—uterine cancer	2.89e-06	9.37e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—KRAS—uterine cancer	2.88e-06	9.35e-05	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—AKT1—uterine cancer	2.88e-06	9.34e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—KRAS—uterine cancer	2.87e-06	9.32e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—KRAS—uterine cancer	2.86e-06	9.29e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—HRAS—uterine cancer	2.84e-06	9.22e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—KRAS—uterine cancer	2.83e-06	9.2e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—TP53—uterine cancer	2.83e-06	9.18e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—KRAS—uterine cancer	2.83e-06	9.18e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—HRAS—uterine cancer	2.83e-06	9.17e-05	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—EP300—uterine cancer	2.76e-06	8.97e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—HRAS—uterine cancer	2.71e-06	8.78e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—PIK3CA—uterine cancer	2.7e-06	8.75e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—PTEN—uterine cancer	2.67e-06	8.65e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—PIK3CA—uterine cancer	2.65e-06	8.61e-05	CbGpPWpGaD
Nortriptyline—CYP2E1—Metabolism—PIK3CA—uterine cancer	2.65e-06	8.6e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—PIK3CA—uterine cancer	2.65e-06	8.59e-05	CbGpPWpGaD
Nortriptyline—CYP3A5—Metabolism—PIK3CA—uterine cancer	2.64e-06	8.58e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—PTEN—uterine cancer	2.64e-06	8.58e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—PIK3CA—uterine cancer	2.64e-06	8.56e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—PIK3CA—uterine cancer	2.63e-06	8.54e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—TP53—uterine cancer	2.61e-06	8.47e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—PIK3CA—uterine cancer	2.6e-06	8.45e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—PIK3CA—uterine cancer	2.6e-06	8.43e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Metabolism—AKT1—uterine cancer	2.57e-06	8.34e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—TP53—uterine cancer	2.57e-06	8.33e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—TP53—uterine cancer	2.56e-06	8.31e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—TP53—uterine cancer	2.55e-06	8.28e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—TP53—uterine cancer	2.54e-06	8.26e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—EP300—uterine cancer	2.54e-06	8.25e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—EP300—uterine cancer	2.52e-06	8.18e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—TP53—uterine cancer	2.52e-06	8.18e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—TP53—uterine cancer	2.51e-06	8.16e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—AKT1—uterine cancer	2.51e-06	8.14e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—AKT1—uterine cancer	2.5e-06	8.1e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—HRAS—uterine cancer	2.49e-06	8.1e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—HRAS—uterine cancer	2.45e-06	7.97e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—HRAS—uterine cancer	2.45e-06	7.95e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—HRAS—uterine cancer	2.44e-06	7.92e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—HRAS—uterine cancer	2.43e-06	7.9e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—HRAS—uterine cancer	2.41e-06	7.82e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—HRAS—uterine cancer	2.4e-06	7.8e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—AKT1—uterine cancer	2.39e-06	7.75e-05	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—PIK3CA—uterine cancer	2.28e-06	7.39e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—PTEN—uterine cancer	2.26e-06	7.33e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—AKT1—uterine cancer	2.2e-06	7.15e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—AKT1—uterine cancer	2.17e-06	7.03e-05	CbGpPWpGaD
Nortriptyline—CYP2E1—Metabolism—AKT1—uterine cancer	2.16e-06	7.03e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—AKT1—uterine cancer	2.16e-06	7.02e-05	CbGpPWpGaD
Nortriptyline—CYP3A5—Metabolism—AKT1—uterine cancer	2.16e-06	7.01e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—AKT1—uterine cancer	2.16e-06	7e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—EP300—uterine cancer	2.15e-06	6.99e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—AKT1—uterine cancer	2.15e-06	6.97e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—AKT1—uterine cancer	2.13e-06	6.91e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—AKT1—uterine cancer	2.12e-06	6.89e-05	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—PIK3CA—uterine cancer	2.04e-06	6.64e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—PIK3CA—uterine cancer	1.88e-06	6.1e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—PIK3CA—uterine cancer	1.86e-06	6.05e-05	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—AKT1—uterine cancer	1.86e-06	6.04e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—PTEN—uterine cancer	1.74e-06	5.66e-05	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—AKT1—uterine cancer	1.67e-06	5.42e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—EP300—uterine cancer	1.66e-06	5.4e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—PIK3CA—uterine cancer	1.59e-06	5.17e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—AKT1—uterine cancer	1.54e-06	4.99e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—AKT1—uterine cancer	1.52e-06	4.94e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—AKT1—uterine cancer	1.3e-06	4.22e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—PIK3CA—uterine cancer	1.23e-06	3.99e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—AKT1—uterine cancer	1e-06	3.26e-05	CbGpPWpGaD
